The Hsp90 Cochaperone P23 is the Limiting Component of the Multiprotein Hsp90/hsp70-based Chaperone System in Vivo Where It Acts to Stabilize the Client Protein: Hsp90 Complex
Overview
Authors
Affiliations
A variety of signaling proteins form heterocomplexes with and are regulated by the heat shock protein chaperone hsp90. These complexes are formed by a multiprotein machinery, including hsp90 and hsp70 as essential and abundant components and Hop, hsp40, and p23 as non-essential cochaperones that are present in much lower abundance in cells. Overexpression of signaling proteins can overwhelm the capacity of this machinery to properly assemble heterocomplexes with hsp90. Here, we show that the limiting component of this assembly machinery in vitro in reticulocyte lysate and in vivo in Sf9 cells is p23. Only a fraction of glucocorticoid receptors (GR) overexpressed in Sf9 cells are in heterocomplex with hsp90 and have steroid binding activity, with the majority of the receptors present as both insoluble and cytosolic GR aggregates. Coexpression of p23 with the GR increases the proportion of cytosolic receptors that are in stable GR.hsp90 heterocomplexes with steroid binding activity, a strictly hsp90-dependent activity for the GR. Coexpression of p23 eliminates the insoluble GR aggregates and shifts the cytosolic receptor from very large aggregates without steroid binding activity to approximately 600-kDa heterocomplexes with steroid binding activity. These data lead us to conclude that p23 acts in vivo to stabilize hsp90 binding to client protein.
Interplay of p23 with FKBP51 and their chaperone complex in regulating tau aggregation.
Chakraborty P, Zweckstetter M Nat Commun. 2025; 16(1):669.
PMID: 39809798 PMC: 11733250. DOI: 10.1038/s41467-025-56028-0.
Defining the Differential Corticosteroid Response Basis from Multiple Omics Approaches.
Ramirez-Falcon M, Suarez-Pajes E, Flores C Int J Mol Sci. 2025; 25(24.
PMID: 39769372 PMC: 11679800. DOI: 10.3390/ijms252413611.
The role of the FKBP51-Hsp90 complex in Alzheimer's disease: An emerging new drug target.
Jeanne X, Torok Z, Vigh L, Prodromou C Cell Stress Chaperones. 2024; 29(6):792-804.
PMID: 39615785 PMC: 11664163. DOI: 10.1016/j.cstres.2024.11.006.
Sahebari M, Rezaieyazdi Z, Khodashahi M, Rafatpanah H, Mehrad-Majd H, Saadati N Caspian J Intern Med. 2023; 14(3):470-478.
PMID: 37520872 PMC: 10379795. DOI: 10.22088/cjim.14.3.470.
Client binding shifts the populations of dynamic Hsp90 conformations through an allosteric network.
Lopez A, Dahiya V, Delhommel F, Freiburger L, Stehle R, Asami S Sci Adv. 2021; 7(51):eabl7295.
PMID: 34919431 PMC: 8682993. DOI: 10.1126/sciadv.abl7295.